HOW LINSITINIB FDA CAN SAVE YOU TIME, STRESS, AND MONEY.

The LIDS trial satisfied its Most important endpoint with statistical significance for that 150mg BID dose. Linsitinib in this trial validated the safety profile observed from the prior oncology research and importantly demonstrated a favorable basic safety profile on critical adverse events (AEs) of interest for your IGF-1R goal for instance Liste